Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan
ID: 360357Type: Posted
Overview

Buyer

Centers for Disease Control - NCBDDD (HHS-CDC-NCBDDD)

Award Range

$0 - $0

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360357
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Promoting Resources and Opportunities for People with Autism and Fragile X and their Families Across the Lifespan." This initiative aims to gather unique data to enhance understanding of the resources and opportunities necessary to improve outcomes for individuals with autism and Fragile X Syndrome (FXS) throughout their lives. The program consists of three components: data collection on autistic teens and young adults, data collection on individuals with FXS, and dissemination of public health products to support these populations. The total estimated funding for this program is $18 million, with 11 awards expected to be made. Interested applicants can reach out to Seema Gupta at (770) 488-6527 or via email at cvk9@cdc.gov for further information. Applications must be submitted electronically by January 30, 2026, with the project anticipated to start on July 1, 2026.

    Point(s) of Contact
    Seema Gupta
    (770) 488-6527
    cvk9@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations" through a cooperative agreement. This initiative aims to support research that gathers timely economic data on immunization from nationally representative samples of the public, including patients and caregivers, to inform economic evaluations of new vaccines. The program is critical for understanding productivity losses related to immunization, particularly for vulnerable populations such as pregnant women and parents of young children. The estimated total funding for this program is $1.2 million, with individual awards ranging from $300,000 to $400,000. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 31, 2026, and project start anticipated on September 1, 2026.
    Comprehensive Suicide Prevention Program for States
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Comprehensive Suicide Prevention Program for States," aimed at implementing and evaluating a comprehensive approach to suicide prevention, particularly for disproportionately affected populations such as veterans, rural communities, and LGBTQ individuals. Eligible applicants must submit proposals with a funding request between $650,000 and $1,200,000, including various letters of commitment and support, as well as a preliminary organizational chart detailing required staff roles. The total estimated program funding is approximately $49.7 million, with an expected 42 awards to be made, and applications must be submitted electronically by 11:59 PM ET on March 3, 2026, with the anticipated award date set for June 19, 2026. For further inquiries, applicants can contact the Comprehensive Suicide Prevention mailbox at csp@cdc.gov.
    Autism Centers of Excellence P50
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Autism Centers of Excellence P50," aimed at soliciting research applications that build on two decades of progress in autism research. This initiative encourages collaborative investigations that leverage cutting-edge technologies and methodologies to advance understanding in this critical area of health. With an estimated total program funding of $10 million and the expectation of awarding three grants, interested applicants are advised to prepare their proposals ahead of the anticipated application period, which is expected to open in July 2026, with a closing date in November 2026. For further inquiries, potential applicants can contact Dr. Alice Kau at Kaua@mail.nih.gov or by phone at 301-496-1385.
    Autism Centers of Excellence R01
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Autism Centers of Excellence R01," aimed at advancing research on autism through collaborative multi-site projects. This initiative seeks applications that leverage innovative technologies and methodologies to build upon 23 years of progress in autism research, with a focus on forming meaningful collaborations among various scientific disciplines. The estimated total program funding is $10 million, with three awards expected, and interested applicants are encouraged to prepare their proposals ahead of the anticipated application opening, which is expected to occur after July 1, 2026. For further inquiries, potential applicants can contact Dr. Alice Kau at Kaua@mail.nih.gov or by phone at 301-496-1385.
    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting research proposals through a cooperative agreement to identify and evaluate potential risk factors for Amyotrophic Lateral Sclerosis (ALS). The opportunity encourages studies focusing on various aspects such as military service, contact sports, traumatic brain injury, neuroinflammation, and infectious agents, with four distinct funding options available to support both established and exploratory research. This initiative aims to enhance understanding of ALS risk factors, particularly in affected populations, and to analyze biological samples related to the Guamanian ALS cluster. Interested applicants can reach out to Dr. Candis Hunter at ncipcerpo@cdc.gov or by phone at 770-488-1347. The total estimated funding for this program is $7.5 million, with individual awards ranging from $0 to $500,000, and proposals are due by December 1, 2025, with awards expected to be announced by August 28, 2026.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering exploratory and developmental grants related to the World Trade Center Health Program (R21) to support research addressing diagnostic and treatment uncertainties for individuals affected by the 9/11 attacks. This funding opportunity aims to encourage innovative research projects that explore new areas of investigation, potentially leading to significant advancements in treatment effectiveness and diagnostic practices for those receiving monitoring and treatment under the James Zadroga 9/11 Health and Compensation Act. With an estimated total program funding of $30 million and an expected 60 awards, applicants can request funding ranging from $0 to $365,000. Interested parties should note that applications are due by 5:00 PM local time on February 12, 2026, and can direct inquiries to Dr. Eduardo O'Neill at 404-718-8844 or via email at fzt4@cdc.gov.
    Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity for the continuation and expansion of the National Mesothelioma Virtual Bank for Translational Research (U24). This cooperative agreement aims to enhance the collection of biospecimens and related data to support biomedical research on malignant mesothelioma, requiring applicants to have an established registry and tissue bank capable of functioning as a national resource. The initiative is crucial for advancing research into early disease markers, treatment modalities, and improving health outcomes for mesothelioma patients. The total estimated funding for this program is $5.5 million, with a ceiling and floor award amount of $1.1 million, and applications must be submitted electronically by March 23, 2026, with an anticipated award date of August 1, 2026. For further inquiries, interested parties can contact Bridgette Garrett at bgarrett@cdc.gov or by phone at 770-488-5715.
    Comprehensive Addiction and Recovery Act (CARA)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is offering grants under the Comprehensive Addiction and Recovery Act (CARA) to support community-based coalitions addressing the crises of opioid, methamphetamine, and prescription drug misuse among youth aged 12-18. Eligible applicants include nonprofit organizations, state and local governments, and other entities that have documented higher-than-average rates of substance misuse, specifically those that are current or former recipients of the Drug-Free Communities (DFC) Support Program. This initiative aims to enhance coalition activities to prevent and reduce substance use among American youth, with a total estimated funding of $16,875,000 available for approximately 45 awards, each ranging from $0 to $75,000. Interested parties should submit their applications electronically by March 16, 2026, and can direct inquiries to Christi Jones at CARANOFO@cdc.gov.
    Drug-Free Communities (DFC) Support Program – NEW (Year 1)
    Centers for Disease Control - NCIPC
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Drug-Free Communities (DFC) Support Program grants for Fiscal Year 2026, aimed at preventing youth substance use. This program seeks to establish and strengthen collaborations among community coalitions, public and private non-profit agencies, and government entities to reduce substance abuse among youth and, over time, among adults by addressing community risk factors. The DFC Support Program is critical for fostering safe and healthy communities, with an estimated total funding of $31,250,000 available for approximately 50 awards, each ranging from $0 to $125,000. Interested applicants, particularly community-based coalitions that have not previously received a DFC grant, must submit their applications electronically by April 14, 2026, with awards expected to be announced by August 31, 2026. For further inquiries, applicants can contact Christi Jones at DFCNOFO@cdc.gov.